196
Views
5
CrossRef citations to date
0
Altmetric
Original Article

Efficacy of hemostatic powders as monotherapy or rescue therapy in gastrointestinal bleeding related to neoplastic or non-neoplastic lesions

ORCID Icon, , , ORCID Icon, , , , & ORCID Icon show all
Pages 1506-1513 | Received 10 Jun 2021, Accepted 23 Aug 2021, Published online: 12 Sep 2021

References

  • Lanas A, García-Rodríguez LA, Polo-Tomás M, et al. Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice. Am J Gastroenterol. 2009;104(7):1633–1641.
  • Hearnshaw SA, Logan RFA, Lowe D, et al. Acute upper gastrointestinal bleeding in the UK: patient characteristics, diagnoses and outcomes in the 2007 UK audit. Gut. 2011;60(10):1327–1335.
  • Fukuda S, Shimodaira Y, Watanabe K, et al. Risks for rebleeding and in-Hospital mortality after gastrointestinal bleeding in a tertiary referral center in Japan. Digestion. 2020;101(Suppl. 1):31–37.
  • Weilert F, Binmoeller KF. New endoscopic technologies and procedural advances for endoscopic hemostasis. Clin Gastroenterol Hepatol. 2016;14(9):1234–1244.
  • Jacques J, Legros R, Chaussade S, et al. Endoscopic haemostasis: an overview of procedures and clinical scenarios. Dig Liver Dis. 2014;46(9):766–776.
  • Holster IL, Kuipers EJ, Tjwa ET. Hemospray in the treatment of upper gastrointestinal hemorrhage in patients on antithrombotic therapy. Endoscopy. 2013;45(1):63–66.
  • Smith LA, Stanley AJ, Bergman JJ, et al. Hemospray application in nonvariceal upper gastrointestinal bleeding: results of the survey to evaluate the application of hemospray in the luminal tract. J Clin Gastroenterol. 2014;48(10):e89–e92.
  • Masci E, Arena M, Morandi E, et al. Upper gastrointestinal active bleeding ulcers: review of literature on the results of endoscopic techniques and our experience with Hemospray. Scand J Gastroenterol. 2014;49(11):1290–1295.
  • Yau AH, Ou G, Galorport C, et al. Safety and efficacy of Hemospray® in upper gastrointestinal bleeding. Can J Gastroenterol Hepatol. 2014;28(2):72–76.
  • Sulz MC, Frei R, Meyenberger C, et al. Routine use of hemospray for gastrointestinal bleeding: prospective two-center experience in Switzerland. Endoscopy. 2014;46(7):619–624.
  • Haddara S, Jacques J, Lecleire S, et al. A novel hemostatic powder for upper gastrointestinal bleeding: a multicenter study (the “GRAPHE” registry)). Endoscopy. 2016;48(12):1084–1095.
  • Rodriguez de SE, Burgos-Santamaria D, Perez-Carazo L, et al. Hemostatic spray powder TC-325 for GI bleeding in a nationwide study: survival and predictors of failure via competing risks analysis. Gastrointest Endosc. 2019; 90:581–590 e6.
  • Alzoubaidi D, Hussein M, Rusu R, et al. Outcomes from an international multicenter registry of patients with acute gastrointestinal bleeding undergoing endoscopic treatment with hemospray. Dig Endosc. 2020;32(1):96–105.
  • Ibrahim M, El-Mikkawy A, Abdel Hamid M, et al. Early application of haemostatic powder added to standard management for oesophagogastric variceal bleeding: a randomised trial. Gut. 2019;68(5):844–853.
  • Laine L, Spiegel B, Rostom A, et al. Methodology for randomized trials of patients with nonvariceal upper gastrointestinal bleeding: recommendations from an international consensus conference. Am J Gastroenterol. 2010;105(3):540–550.
  • Chahal D, Lee JGH, Ali-Mohamad N, et al. High rate of re-bleeding after application of hemospray for upper and lower gastrointestinal bleeds. Dig Liver Dis. 2020;52(7):768–772.
  • Baracat FI, de Moura DTH, Brunaldi VO, et al. Randomized controlled trial of hemostatic powder versus endoscopic clipping for non-variceal upper gastrointestinal bleeding. Surg Endosc. 2020;34(1):317–324.
  • Facciorusso A, Straus Takahashi M, Eyileten Postula C, et al. Efficacy of hemostatic powders in upper gastrointestinal bleeding: a systematic review and Meta-analysis. Dig Liver Dis. 2019;51(12):1633–1640.
  • Ofosu A, Ramai D, Latson W, et al. Endoscopic management of bleeding gastrointestinal tumors. Ann Gastroenterol. 2019;32(4):346–351.
  • Chen YI, Barkun AN, Soulellis C, et al. Use of the endoscopically applied hemostatic powder TC-325 in cancer-related upper GI hemorrhage: preliminary experience (with video). Gastrointest Endosc. 2012;75(6):1278–1281.
  • Leblanc S, Vienne A, Dhooge M, et al. Early experience with a novel hemostatic powder used to treat upper GI bleeding related to malignancies or after therapeutic interventions (with videos). Gastrointest Endosc. 2013;78(1):169–175.
  • Chen YI, Wyse J, Lu Y, et al. TC-325 hemostatic powder versus current standard of care in managing malignant GI bleeding: a pilot randomized clinical trial. Gastrointest Endosc. 2020;91(2):321–328.
  • https://www.accessdata.fda.gov/cdrh_docs/reviews/DEN170015.pdf.
  • Hagel AF, Albrecht H, Nägel A, et al. The application of hemospray in gastrointestinal bleeding during emergency endoscopy. Gastroenterol Res Pract. 2017;2017:3083481.
  • Vitali F, Naegel A, Atreya R, et al. Comparison of hemospray® and endoclot™ for the treatment of gastrointestinal bleeding. World J Gastroenterol. 2019;25(13):1592–1602.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.